Invention Grant
- Patent Title: Pancreatic cancer genes
-
Application No.: US12645412Application Date: 2009-12-22
-
Publication No.: US08030455B2Publication Date: 2011-10-04
- Inventor: Giulia Kennedy
- Applicant: Giulia Kennedy
- Applicant Address: US CA Emeryville
- Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.
- Current Assignee Address: US CA Emeryville
- Agent Patricia Tsao
- Main IPC: C07K16/00
- IPC: C07K16/00

Abstract:
The present invention provides the art with the DNA coding sequences of polynucleotides that are up-or-down-regulated in cancer and dysplasia. These polynucleotides and encoded proteins or polypeptides can be used in the diagnosis or identification of cancer and dysplasia. Inhibitors of the up-regulated polynucleotides and proteins can decrease the abnormality of cancer and dysplasia. Enhancing the expression of down-regulated polynucleotides or introducing down-regulated proteins to cells can decrease the growth and/or abnormal characteristics of cancer and dysplasia.
Public/Granted literature
- US20100324272A1 PANCREATIC CANCER GENES Public/Granted day:2010-12-23
Information query